RedCarpetLife
2902
In the world today
Xavier Rubiralta

Xavier Rubiralta

X. Rubiralta
0.27% | + $3.35M
$1.26 B ₹ 11,836 Cr
Real Time Net Worth #2902 Ranking as of 21 Mar 2026 By Forbes

More on Xavier Rubiralta

Gender

Male

Age

54Y

Country

Spain

Born On

January, 1972

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

No

Entrepreneur Type

Inherited (Healthcare)

Primary Organization

Werfen

Titles

Shareholder & Board Member

Sources of Wealth

Medical Diagnostics

Industry

Healthcare, Medical Devices

About Xavier Rubiralta


X avier Rubiralta is a Spanish billionaire and a key shareholder in Werfen, a global leader in specialized diagnostics and medical devices. He inherited his stake in the company from his father, Josep Maria Rubiralta, who founded the business in 1966 in Barcelona. Xavier has served on the board of directors since 2013, helping to guide the family-owned company's strategic direction.

Werfen specializes in critical areas such as hemostasis, acute care diagnostics, and autoimmunity. Under the stewardship of Xavier and his brothers—Jordi, Jose Luis, and Marc—the company has expanded internationally through organic growth and acquisitions, including the purchase of U.S.-based Instrumentation Laboratory. The Rubiralta family remains one of the wealthiest in Catalonia, maintaining private control over their healthcare empire.

Advertisement

Quick Reads


Early Life and Background


Xavier Rubiralta is a Spanish businessman whose fortune stems from Spain-based diagnostics company Werfen. Werfen specializes in medical areas such as hemostasis, acute care, transfusion, autoimmunity and transplants.

Werfen's roots stem from his father and uncle who founded the business in 1966 as a health products distributor. Xavier inherited his stake in the company from his late father in 2012.

  • Core Company: Werfen (Diagnostics company).
  • Family Founding: Father and uncle founded the business in 1966.
  • Key Areas: Specializes in hemostasis, acute care, and transplants.

Career Journey of Xavier Rubiralta


Xavier Rubiralta's career is defined by his role in the governance and stewardship of the family enterprise. He inherited his stake in 2012 and has been a member of Werfen's board since 2013.

The company expanded significantly over the years, notably acquiring U.S.-based Instrumentation Laboratory in 1991. The family maintains control through the ownership structure: his brothers Jordi, Jose Luis and Marc also inherited equal stakes from his father and are also billionaires.

  • Family Role: Member of Werfen's board since 2013.

Advertisement

Xavier Rubiralta's Timeline


1966:

Werfen was founded by his father and uncle.

1991:

Acquired U.S.-based Instrumentation Laboratory.

2012:

Inherited his stake from his late father.

2013:

Became a member of Werfen's board.

Major Business Ventures and Investments


Xavier Rubiralta's wealth is concentrated in his family's substantial ownership stake in the private healthcare giant, Werfen.

  • Werfen (Board Member): Diagnostics company specializing in hemostasis, acute care, and transplants.
  • Key Acquisition: Acquired U.S.-based Instrumentation Laboratory in 1991.
  • Sector Focus: Medical diagnostics and healthcare products.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He owes his fortune to Spain-based Werfen, a diagnostics company specializing in hemostasis, acute care, and transplants.
  • He inherited his stake in 2012 and has been on the board since 2013.
  • His father and uncle founded the business in 1966.
  • His brother Jordi, Jose Luis and Marc also inherited equal stakes and are billionaires.

Advertisement

More Profiles


Li Ge

Li Ge

#513

+0.26% | +$18.84M

Cho Jung-ho

+0.01% | +$0.76M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content